Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.

Desreumaux P, Ghosh S.
INSERM U795, Lille, France. This email address is being protected from spambots. You need JavaScript enabled to view it.
Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9.

Read more...

PPARgamma as a new therapeutic target in inflammatory bowel diseases

Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P.
INSERM U795 ex E114, Clinique des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Swynghedauw, rue A Verhaeghe, F-59037 Lille Cedex, France.
Gut. 2006 Sep;55(9):1341-9.

Read more...

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P.
INSERM U795, F-59037 Lille cedex, France.
Gut. 2007 Apr;56(4):577-83. Epub 2006 Sep 6.

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P.
Institut National de la Santé et de la Recherche Médicale (INSERM) U795, Hôpital Swynghedauw, Rue A Verhaeghe, 59037 Lille Cedex, France.
Nat Med. 2007 Jan;13(1):35-7.

Read more...

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel JF, Darfeuille-Michaud A.
Groupe de Recherche Pathogénie Bactérienne Intestinale, Université d'Auvergne, USC-INRA 2018, Clermont-Ferrand, France.
J Clin Invest. 2007 Jun;117(6):1566-74. Epub 2007 May 24.

Read more...